Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, published on major advances to Enchant, Iambic's ...

and NeuralPLexer (best-in-class predictor of protein and protein-ligand structures). The integration of physics principles into the platform’s AI architectures improves data efficiency and ...

Onctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today announces it has dosed the first patient in the randomized Phase I/II study investigating lead ...

Ainnocence, a leader in next-generation AI drug-discovery solutions, today released a comprehensive white paper detailing ...

Ribonucleic acid (RNA) molecules may be best known for their job ferrying the genetic information encoded in DNA to a cell's ...

We developed a ligand-responsive solid-state condensate ... RNA and protein in engineered nuclear condensate structures as an efficient alternative for regulating gene expression.

Institute of Chemistry, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Givat Ram, 9190401 Jerusalem, Israel Institute of Chemistry, The Hebrew University of Jerusalem, Edmond J. Safra ...

School of Nano-Tech and Nano-Bionics, University of Science and Technology of China, Hefei 230026, P. R. China Suzhou Institute of Nano-tech and Nano-bionics, Chinese Academy of Sciences, Suzhou ...

1 Voting power varies on certain matters pertaining to the General Department with use of the Fund's resources in that Department. 2 Percentages of total votes (5,041,052) in the General Department ...